Navigation Links
Dr. Larry Corey Named New Member of the Institutes of Medicine
Date:10/13/2008

SEATTLE, Oct. 13 /PRNewswire/ -- Larry Corey, M.D., senior vice president and co-director of the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center, today was named as one of 65 new members of the prestigious Institutes of Medicine (IOM).

Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. Members are elected through a highly selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health.

"I am honored by the recognition," Corey said. With a tip of the hat to those who work in his labs, Corey added, "I thank all of the smart fellows, post docs, technicians and collaborators who have made me look so good over the years. I hope I continue to stay out of their way and allow them to pursue their ideas, with just the right touch of guidance from me."

With their election to the IOM, members make a commitment to volunteer a significant amount of time to IOM committees, which engage in a broad range of studies on health policy issues.

Corey is principal investigator of the HIV Vaccine Trials Network, which is based at the Hutchinson Center. He is also head of the University of Washington's Virology Division and is a professor of medicine and laboratory medicine at the UW School of Medicine.

Research in Corey's labs includes studies dealing with the pathogenesis, prevention and treatment of HIV and herpes virus infections. These investigations include the development of experimental vaccines for both genital herpes and HIV. The labs have also pioneered novel tests for diagnosing and monitoring therapies for viral infections.

Contact: Kristen Woodward, 206-667-5095 or kwoodwar@fhcrc.org


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. A Statement From Larry Corey, MD, of the HIV Vaccine Trials Network Regarding the New HIV Infection Statistics Released Today by the Centers for Disease Control
2. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
3. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
4. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
5. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
6. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
7. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
8. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
9. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
10. Ikaria Founding Scientist Named 2007 MacArthur Fellow
11. BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... were treated with a statin in the hospital after ... to survive than those who were not, according to ... This study was conducted by the same researchers who ... improve survival in victims of ischemic stroke., Ischemic stroke ... blood vessel that blocks blood from reaching areas of ...
(Date:9/22/2014)... Research and Markets ( ... "Global Biotechnology Reagents Market 2014-2018" report ... Biotechnology reagents are chemical compounds or ... detect and examine another substance to provide a ... to prepare, collect, and examine specimens from the ...
(Date:9/22/2014)... (CTCs) in a mouse model of pancreatic cancer identified ... CTCs, including significant differences from the primary tumor that ... In their study reported in the Sept. 25 issue ... General Hospital (MGH) Cancer Center identified several different classes ... prove to be targets for improved treatment of the ...
(Date:9/22/2014)... Researchers have discovered a way to create a highly ... graphene sheets. The imperfections have unique electronic properties that ... to absorbed gas molecules by 300 times. , The ... Nature Communications . , Amin Salehi- Khojin, asst ... with Mohammad Asadi, graduate student and Bijandra Kumar, post ...
Breaking Biology Technology:Statin use during hospitalization for hemorrhagic stroke associated with improved survival 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3Massachusetts General study reveals gene expression patterns in pancreatic CTCs 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 3Graphene imperfections key to creating hypersensitive 'electronic nose' 2
... of investigational sustained follicle stimulant achieves similar efficacy to ... week period in Phase III Study , , ... SGP ) today announced results from the Phase III ... corifollitropin alfa, first in the class of sustained follicle ...
... a subsidiary of Eisai Corporation of North America, announced ... express and develop therapeutic monoclonal antibodies for the potential ... , , Under the terms of the agreement, ... technology and its expertise to produce and develop a ...
... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that ... device and methods for linking biological agents to labels for ... as In-Line labeling, was developed for the production of radiolabeled ... A study published today in the July 2009 issue ...
Cached Biology Technology:Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease 2Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 4
(Date:9/22/2014)... the University of Chicago have shown that after a ... a handful of pathogenic microbe species remain behind in ... discovered that some can become deadly when provoked by ... , The findings, published in mBio , the ... may lead to better monitoring and treatment of ICU ...
(Date:9/22/2014)... --- Many native species have vanished from tropical ... Florida scientists have discovered how fossils can be ... key lies in organic materials found in fossil ... functioned, according to a new study available online ... Journal of Herpetology . Pre-human island ecosystems provide ...
(Date:9/22/2014)... of cut grass in recent years has been identified ... research says the aroma also summons beneficial insects to ... the plant signals the environment via the emission of ... queue for parasitic wasps to come to the plant ... pest insect," said Dr. Michael Kolomiets, Texas A&M AgriLife ...
Breaking Biology News(10 mins):Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 3Answer to restoring lost island biodiversity found in fossils 2Mown grass smell sends SOS for help in resisting insect attacks, researchers say 2Mown grass smell sends SOS for help in resisting insect attacks, researchers say 3
... at St. Jude Children's Research Hospital have discovered how a ... effects ranging from learning and memory capabilities to glucose production ... called CREB, is a transcription factor—a molecule that binds to ... gene to make the specific protein for which it codes. ...
... provides the most compelling evidence to-date that some dinosaurs ... del Campo track site in Spain's Cameros Basin, contains ... a non-avian therapod dinosaur. , A team led ... La Rioja, Spain, discovered the prints in an area ...
... guys that help bacterial pathogens do their job of infecting ... essence, they knock down the front door of resistance and ... University of California, San Diego (UCSD) School of Medicine have ... YpkA, one of several effectors of the bacteria Yersinia – ...
Cached Biology News:St. Jude study shows genes play an unexpected role in their own activation 2Definitive evidence found of a swimming dinosaur 2How plague-causing bacteria disarm host defense 2
Request Info...
Size & Applications: 100 ul (2 mM). Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.) Storage Temp.: -20C Shelf Life: 6-12 month...
in vitro Translation, Accessory Products...
... Origami host strains are K-12 derivatives ... reductase (trxB) and glutathione reductase (gor) genes, ... the cytoplasm. Studies have shown that expression ... than in another host even though overall ...
Biology Products: